Unknown PHASE4 INTERVENTIONAL 1-arm NCT02012140

Pharmacokinetics and Pharmacodynamics of Ticagrelor in Patients With Stable Angina, NSTEMI and STEMI Undergoing PCI

Sponsor: LifeBridge Health

Conditions Cardiovascular Disease Coronary Artery Disease Myocardial Infarction Stable Angina

Interventions ticagrelor

Updated 6 times since 2017 Last updated: Dec 10, 2013 Started: Jan 31, 2014 Primary completion: Jan 31, 2015

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE4 clinical study on Cardiovascular Disease and Coronary Artery Disease, this trial is ongoing. The trial is conducted by LifeBridge Health and has accumulated 6 data snapshots since 2014. Cardiovascular trials of this type often inform treatment guidelines for long-term patient management.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Unknown PHASE4
Jul 2024 — Sep 2024 [monthly]

Unknown PHASE4

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status PHASE4
Jun 2018 — Jan 2021 [monthly]

Unknown Status PHASE4
Feb 2017 — Jun 2018 [monthly]

Unknown Status PHASE4

▶ Show 1 earlier version

Jan 2017 — Feb 2017 [monthly]

Unknown Status PHASE4

First recorded

Jan 2014

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

LifeBridge Health

Data source: LifeBridge Health

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Baltimore, United States